MedTrace Logo

Effects of Hip Abductor Strengthening Exercises in Patients With Piriformis Syndrome

NCT07484373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-03-20

No results posted yet for this study

Summary

The study was conducted to determine the effects of hip abductor strengthening exercises on pain, range of motion, and lower extremity function in patients with piriformis syndrome.

Conditions

  • Piriformis Syndrome

Interventions

OTHER

Progressive Hip Abductor Strengthening Exercises

Experimental Group (Hip Abductor Strengthening + Baseline Physiotherapy) A structured hip abductor strengthening program divided into three progressive phases over four weeks, along with baseline physiotherapy treatment. Phase I (Week 1 - Non-weight bearing / Isolated activation) Exercises: Bridging, Side-lying clam exercises, Side-lying hip abduction, Towel squeeze Dosage: 3 × 15 repetitions Phase II (Week 2 - Weight-bearing strengthening) Exercises: Squats, Side-stepping, Single-limb sit-to-stand, Step-up/Step-down, Leg press Dosage: 3 × 15 repetitions Phase III (Weeks 3-4 - Dynamic/Functional training) Exercises: Forward lunges, Double-limb jump Dosage: Week 3 → 3 × 15 repetitions Week 4 → 5 × 20 repetitions

OTHER

conventional physiotherapy treatment

conventional Physiotherapy treatment * Hydro-collateral pack for 10 minutes over piriformis muscle (40°C) * Pulsed ultrasound for 10 minutes at 2.25 W/cm² * Piriformis stretching maneuver (20-second hold × 10 repetitions)

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Humera Mubashar, Ms-OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2025-05-31
Completion
2025-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07484373 on ClinicalTrials.gov